HOME >> MEDICINE >> NEWS
SNM and ACNP CMS PET reimbursement statement

CMS new reimbursement rate for FDG PET of $1375.00 has both good and disappointing news for those interested in bringing Positron Emission Tomography (PET) to the broadest number of patients, according to the Society of Nuclear Medicine (SNM) and the American College of Nuclear Physicians (ACNP).

SNM and ACNP believe that this lower rate (down from the previous $2,331.18) may have a negative impact on the expansion of PET services into communities where it does not currently exist, since it will be more difficult for hospitals and other facilities to recoup the significant costs associated with the installation and operation of PET centers. This is unfortunate, since PET is increasingly used in clinical medicine, and is a vital diagnostic and treatment planning tool for many cancers, neurological and cardiac conditions.

On the positive side, SNM and ACNP are pleased at CMSs responsiveness to the concerns expressed when proposed reduced reimbursement amounts were first posted in August. This was particularly significant as it relates to the cost of the 18-flurodeoxyglocose (FDG) injected as part of the PET scan process. CMS originally proposed an FDG PET reimbursement of $841.50, when the published average wholesale price (AWP) for FDG is $750. Facilities would lose money with each scan.

This process demonstrated that the medical profession and the government can work together, stated Alan Maurer, M.D., President of the SNM. We were able to show how there were errors in the data on which CMS had originally based its proposed reimbursement, and the agency responded by developing a more reasonable, though still disappointing, reimbursement amount.

Because CMS relies on data to make its reimbursement decisions, this effort also demonstrates how important it is for those of us in the PET field to be particularly precise when we code and submit claims to the agency. We look forward to working with CMS in the future on this, and to e
'"/>

Contact: William Uffelman
wuffelman@snm.org
703-708-9000
Society of Nuclear Medicine
30-Nov-2001


Page: 1 2

Related medicine news :

1. Study finds Medicare overbilling may be caused by governments faulty reimbursement
2. NHLBI statement on oral contraceptive study
3. NIH panel issues State-of-the-Science statement on end-of-life care
4. Doctors statement in Mayo Clinic Proceedings reveals dark side of low-carb diets
5. American Heart Association consensus statement
6. NIA statement on IOM testosterone report
7. American Psychiatric Association issues statement on compulsive shopping
8. New statement proposes ways to stop deadly drug errors among heart, stroke patients
9. Aventis Pasteur statement on HVTN 501 decision

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: SNM and ACNP CMS PET reimbursement statement

(Date:5/24/2015)... Metamora, Michigan (PRWEB) May 24, 2015 ... for concerns about hair loss. Although it is unclear ... that there are environmental factors such as metabolism, nutritional ... contribute. Since they offer a comprehensive approach to evaluating ... and post-menopausal woman, they can help patients find a ...
(Date:5/24/2015)... Lake Orion, Clarkston, Metamora, Michigan (PRWEB) May 24, 2015 ... tests, which will allow them to take pressure measurements ... about bladder function. The doctor usually orders it if ... or overactive bladder (OAB). , Women’s Excellence ... that have problems with unwanted urinary leakage or problems ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 EnviroLeather™ ... launches “InkGard™ Plus” – a classic, rugged leather ... polymer allowing difficult stains, including ink, to be ... different colors suitable for corporate, healthcare, hospitality and ... line with EnviroLeather’s goal of developing products that ...
(Date:5/24/2015)... Viejo, CA (PRWEB) May 24, 2015 ProPin ... use in Final Cut Pro X. Utilize ProPin to pin ... in a given scene. , ProPin allows users to ... completely customizable in FCPX. With on-screen controls, video editors can ... allows users to pin and mark with absolute ease. , Using ...
(Date:5/24/2015)... 2015 Medicx Media Solutions ... executive Jay Krihak as its head of programmatic ... up its expertise and leadership position in the ... Health sectors. , Krihak is an experienced, award-winning ... Krihak led sales planning teams for mobile platform ...
Breaking Medicine News(10 mins):Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Medicx Media Solutions Expands Executive Team 2
(Date:5/22/2015)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... the results of the Company,s 72-patient, placebo-controlled Phase ... for the treatment of dry eye patients using ... model.  The exploratory study was completed in late ... by the Company in a press release, identify ...
(Date:5/22/2015)... 20, 2015 Research and Markets( http://www.researchandmarkets.com/research/28m7nx/guide_to_prepare ... "Guide to Prepare Application Dossiers for Oversea Medical ... " report to their offering. ... segment market of the most growth potentiality, which ... manufacturers and producers to penetrate such market. It ...
(Date:5/22/2015)... 2015 Today, Rhodes Pharmaceuticals L.P. announced that ... indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) ... The announcement comes just one ... U.S. Food and Drug Administration (FDA). ... methylphenidate capsule with an onset of effect of ...
Breaking Medicine Technology:Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 2Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 3Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 4Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 5Rhodes Pharmaceuticals Announces Launch of New, Once-Daily Treatment for ADHD 6
Cached News: